11. Heart Health 101: Cardiovascular Disease, Longevity, Lp(a) and Smarter Testing

Heart Health & Longevity: Cardiovascular Disease, Lp(a), and Smarter Testing Summary Cardiovascular disease (CVD) remains the #1 killer in America—claiming one life every 36 seconds and costing the U.S. economy over $365 billion annually. But here’s the hopeful truth: much of it is preventable. In this episode, Drs. Nisha and Vikas Patel take you on a practical, evidence-based deep dive into heart health. From sobering statistics and risk factors to advanced screening tools and new therapies, this conversation will leave you with a clear roadmap for protecting your most vital organ. And yes, there’s humor too—because talking about stents, statins, and stress tests doesn’t have to be dry.   What You’ll Learn: The Scope of the Problem 655,000 Americans die annually from CVD. 126 million adults are living with some form of CVD. Annual cost exceeds $365 billion (medical care + lost productivity). Risk Factors Non-modifiable: age, sex, genetics, family history. Modifiable: high blood pressure, high LDL/ApoB, diabetes, smoking, inactivity, and excess visceral fat. Why hypertension is called the “silent killer” and why new guidelines lowered the bar to 130/80. Why we now prioritize ApoB over LDL cholesterol. Pathophysiology Simplified How atherosclerosis develops from endothelial damage to plaque rupture. Why the most dangerous plaques aren’t always the most narrowed. The role of inflammation and what the CANTOS trial taught us. Advanced Screening Tools ApoB testing for particle number. Coronary artery calcium (CAC) scoring: score of 0 = low risk; >400 = high risk. CT angiography: visualizing both calcified and non-calcified plaque. The Lipoprotein(a) Deep Dive Elevated in ~20% of people, but rarely measured. Doubles coronary heart disease risk, increases risk of aortic stenosis and stroke. Almost entirely genetic, unaffected by diet/exercise/statins. New therapies in clinical trials could reduce levels by 80–90%. Until then: double down on controllable risk factors. Evidence-Based Risk Reduction Diet: Mediterranean diet lowers major CV events by 30% (PREDIMED trial). Exercise: 150 minutes/week of moderate activity = 30% lower CV mortality. Medications: Statins: 20–25% reduction in CV events. Ezetimibe & PCSK9 inhibitors: powerful LDL lowering, though costly. Blood pressure meds: effective across multiple classes—choice matters less than control. Practical Implementation Know your numbers: LDL, ApoB, Lp(a), BP, A1c, VO₂ max, visceral fat. Get a baseline with advanced screening (DEXA, CAC, CT). Build habits: strength training + cardio, Mediterranean-style nutrition, stress and sleep hygiene. Medications when appropriate—don’t let “perfect” be the enemy of good. Call to Action CVD prevention is not just possible—it’s powerful. Know your numbers, track your risks, and take proactive steps to protect your heart. At MD Longevity Lab, we use tools like VO₂ max testing, full-body DEXA, ApoB and Lp(a) labs, and calcium scoring to create personalized heart health strategies. Don’t wait for a cardiac event—get ahead of the game.